3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid
TL;DR: 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid (CAS 384358-01-4) is a chemical compound with molecular formula C22H20N2O6 and molecular weight 408.13 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid
Also Known As: 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid, 3-{5-[(E)-{2-[(3,4-dimethoxyphenyl)acetyl]hydrazinylidene}methyl]furan-2-yl}benzoic acid, (E)-3-(5-((2-(2-(3,4-dimethoxyphenyl)acetyl)hydrazono)methyl)furan-2-yl)benzoic acid, 3-(5-{[2-(3,4-Dimethoxy-phenyl)-acetyl]-hydrazonomethyl}-furan-2-yl)-benzoic acid, 3-[5-[[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]-2-furyl]benzoic Acid
| Molecular Formula | C22H20N2O6 |
|---|---|
| Molecular Weight | 408.13 g/mol |
| LogP | 3.3548 |
| Topological Polar Surface Area | 110.36 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Exact Mass | 408.13214 |
| Heavy Atoms | 30 |
| Complexity | 1086.7367 |
Chemical Identifiers
| CAS Number | 384358-01-4 |
|---|---|
| SMILES | COC1=C(C=C(C=C1)CC(=O)N/N=C/C2=CC=C(O2)C3=CC(=CC=C3)C(=O)O)OC |
Product Overview
3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid (CAS 384358-01-4), with molecular formula C22H20N2O6 and molecular weight 408.13 g/mol. IUPAC: 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid.
Chemical Property Profile of 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid
Property Insights of 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid
The XLogP value of 3.3548 indicates that 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 110.36 Ų falls within the moderate polarity range, balancing permeability and solubility for 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid. Following Lipinski's Rule of Five, 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid has 2 hydrogen bond donor(s) and 6 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid?
The CAS number of 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid is 384358-01-4.
What is the molecular formula of 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid?
The molecular formula of 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid is C22H20N2O6.
What is the molecular weight of 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid?
The molecular weight of 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid is 408.13 g/mol.
Where can I buy 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid?
You can request a quote for 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid?
Yes, KEHONG BIO provides custom synthesis services for 3-[5-[(E)-[[2-(3,4-dimethoxyphenyl)acetyl]hydrazinylidene]methyl]furan-2-yl]benzoic acid and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.